Application In Synthesis of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG in [Imamura, Fumiaki; Koulman, Albert; Wareham, Nick J.; Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Fretts, Amanda M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Marklund, Matti; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden; [Marklund, Matti; Wu, Jason H. Y.] Univ New South Wales, George Inst Global Hlth, Fac Med, Sydney, NSW, Australia; [Marklund, Matti; Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Ardisson Korat, Andres V.; Hu, Frank] Harvard TH Chan Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA USA; [Ardisson Korat, Andres V.; Hu, Frank; Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Ardisson Korat, Andres V.; Djousse, Luc; Hu, Frank; Sun, Qi] Harvard Med Sch, Boston, MA 02115 USA; [Yang, Wei-Sin; Chien, Kuo-Liong; Chen, Yun-yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Lankinen, Maria; Virtanen, Jyrki K.; Tuomainen, Tomi-Pekka; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Qureshi, Waqas] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA; [Helmer, Catherine; Rajaobelina, Kalina; Samieri, Cecilia] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France; [Chen, Tzu-An; Wood, Alexis C.; Senn, Mackenzie] USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX USA; [Wong, Kerry; Bassett, Julie K.; Giles, Graham G.; Hodge, Allison] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia; [Murphy, Rachel] Univ British Columbia, Sch Populat Publ & Hlth, Ctr Excellence Canc Prevent, Fac Med, Vancouver, BC, Canada; [Tintle, Nathan] Dordt Univ, Dept Math & Stat, Sioux Ctr, IA USA; [Yu, Chaoyu Ian; McKnight, Barbara] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Hlth Sci, Fac Sci, Amsterdam, Netherlands; [Chien, Kuo-Liong; Chen, Yun-yu] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [del Gobbo, Liana C.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Djousse, Luc] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Geleijnse, Johanna M.; de Goede, Janette; Soedamah-Muthu, Sabita S.] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Netherlands; [Giles, Graham G.; Hodge, Allison] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Giles, Graham G.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia; [Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Harris, William S.] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA; [Harris, William S.] OmegaQuant Analyt, Sioux Falls, SD USA; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Nutr Biomarker Lab, Cambridge, England; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Metabol & Lipid Lab, Cambridge, England; [Koulman, Albert] MRC, Elsie Widdowson Lab, Cambridge, England; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lin, Hung-Ju] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Robinson, Jennifer G.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Prevent Intervent Ctr, Iowa City, IA USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Soedamah-Muthu, Sabita S.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders, Tilburg, Netherlands; [Soedamah-Muthu, Sabita S.] Univ Reading, Inst Food Nutr & Hlth, Reading, Berks, England; [Sotoodehnia, Nona; Lemaitre, Rozenn N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wagenknecht, Lynne E.] Wake Forest Sch Med, Publ Hlth Sci, Winston Salem, NC 27101 USA published Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies in 2020.0, Cited 47.0. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5.
Background De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). Methods and findings Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-varianceweighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p< 0.001) for 16:0, 1.40 (1.33-1.48; p< 0.001) for 16:1n-7, 1.14 (1.05-1.22; p = 0.001) for 18:0, and 1.16 (1.07-1.25; p< 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I-2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. Conclusions Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D.
Application In Synthesis of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG or concate me.
Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem